GlobalData: Diagnosed prevalent cases of angina pectoris expected to reach 22.79 million in 2028

The diagnosed prevalent cases of angina pectoris is expected to increase from 19.58 million cases in 2018 to 22.79 million cases in 2028, at an annual growth rate (AGR) of 1.64% across the seven major markets 7MM, according to GlobalData, a leading data and analytics company.

GlobalData: Diagnosed prevalent cases of angina pectoris expected to reach 22.79 million in 2028

Of the 7MM, the US is expected to have the highest number of diagnosed prevalent cases in 2018 and increasing at an AGR of 2.04% (2018­–2028), followed by Germany (1.01%) and France (1.80%).

The company’s latest report, ‘GlobalData (2020). Angina Pectoris - Epidemiology Forecast Report to 2028,’ notes that the major drivers for the upward trend in the diagnosed prevalent cases of angina pectoris in both sexes in the 7MM over the next decade may be attributable to advancing age, family history of premature coronary artery diseases, cigarette smoking, diabetes mellitus, hypercholesterolemia, or systemic hypertension, and changing population demographics in the respective markets.

The aetiology of angina pectoris is not fully understood and it is a largely untreatable condition. There is also an urgent need for further research to gather country-specific epidemiological data to better understand the etiology and underlying risk factors of angina pectoris; such knowledge could help tackle the burden of angina pectoris.”

Suneedh Manthri, Associate Project Manager of Epidemiology at GlobalData

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer